Ranbaxy Laboratories: Global Research Company

Ranbaxy Laboratories is a research-based pharmaceutical company with customers in more than 150 countries around the world. For more than 50 years now, the company has been providing high-quality, affordable medicines that both patients and healthcare professionals trust. A part of the Daiichi Sankyo Group, a leading global innovator in the pharmaceutical industry, Ranbaxy operates in 43 countries and has 21 manufacturing facilities in eight of those. A robust presence in both emerging and developed markets allows the company to cover all top 25 pharmaceutical markets available.

A vertically integrated company, Ranbaxy not only develops and manufacturers but also markets various generic and branded generic, value-added, and OTC products, as well as intermediates, active pharmaceutical ingredients, and anti-retrovirals. With a portfolio encompassing more than 500 molecules for use in tables, capsules, inhalers, injectables, creams, ointments, and liquids, Ranbaxy makes its presence felt across treatments and therapies, including pain management, anti-infectives, and nutritionals.

Ranbaxy was founded by Ranbir and Gurbax Singh in 1937. Back then, it was as a distributor for Shionogi, a Japanese company. Ranbaxy got its name from its founder's names, Ranbir and Gurbax. Their cousin Bhai Mohan Singh bought the company from the two in 1952 and when Bhai Mohan's son Parvinder joined, Ranbaxy enjoyed improved growth.

It was in June 2008 when Daiichi Sankyo acquired a stake in the company, valued at $2.4 billion. Come November of the same year, Daiichi Sankyo was able to complete the takeover of Ranbaxy, sealed with a $4.6 billion deal which gave the former a 63.92% stake in the latter. Ranbaxy follows a business philosophy that delivers optimum value to stakeholders and constantly inspires employees to excel and set global standards. With a workforce of over 14,600 individuals, bringing together more than 50 nationalities, the company finds strength to not only improve the quality of healthcare but make it accessible as well to people all over the world.